VTRS — Viatris
Data coverage, completeness and provenance for Viatris in the Stock Market API — Health Care · Drug Manufacturers - Specialty & Generic.
Stored price coverage
Source date: 2026-11-19T21:00:00. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-11-19 | 19.8800 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-18 | 20.2800 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-17 | 20.4500 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-16 | 20.7400 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-13 | 20.8200 | USD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/VTRS/prices · Price parameters and adjustment semantics
No archived filings are currently stored for this listing.
Profile
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
Employees: 30,000 · Website: https://www.viatris.com · Profile fields populated: 75%
Data completeness by statement
Share of stored fields populated in the anchor reporting period (FY2025), primary source sec_edgar. Full per-field breakdown: GET /api/v1/companies/VTRS/financials.
Financial statement coverage (USD)
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2025 (USD) | 2025-12-31 | 29 | sec_edgar | ||||
| FY2024 (USD) | 2024-12-31 | 29 | sec_edgar | ||||
| FY2023 (USD) | 2023-12-31 | 30 | sec_edgar | ||||
| FY2022 (USD) | 2022-12-31 | 30 | sec_edgar | ||||
| FY2021 (USD) | 2021-12-31 | 31 | sec_edgar |
Get VTRS data via the API
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Company profile
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/VTRS
Financial statements
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/VTRS/financials
Computed ratios
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/VTRS/metrics/summary
News & announcements
Dated press releases and announcements with source links.
GET /api/v1/companies/VTRS/news
Quick start
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/VTRS
Query VTRS programmatically
Free tier — instant API key. Built for AI agents.
Other NASDAQ · Health Care companies covered
Frequently Asked Questions
- What data does the API provide for VTRS?
- Stored coverage for VTRS: price data available, financial statements available, 0 archived filings. REST endpoints are under /api/v1/companies/VTRS; inspect available source metadata for provenance.
- How complete is VTRS's financial data?
- The anchor reporting period (FY2025) has 88.2% of the 17 core statement fields populated. Primary source: sec_edgar.
- What reporting periods are covered for VTRS?
- 5 fiscal-year periods are stored (FY2021–FY2025), with per-period field counts and source tags available via /api/v1/companies/VTRS/financials.
- Where does VTRS's data come from?
- Stored price source: yfinance. Primary source for the statement snapshot: sec_edgar. Inspect available period and field source tags at /api/v1/companies/VTRS/financials; missing tags do not establish provenance.